Tengjun Biotechnology (TJBH) 10-Q 1 Nov 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 01, 2016
Document and Entity Information
Entity Registrant Name	China Herb Group Holdings Corp
Entity Central Index Key	1,499,785
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		37,493,120

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents		$ 1,795
Prepaid expenses	7,792
TOTAL CURRENT ASSETS	7,792	1,795
TOTAL ASSETS	7,792	1,795
CURRENT LIABILITIES:
Bank overdrafts	36
Accounts payable	1,160	4,340
Related party loans	188,505	153,748
TOTAL CURRENT LIABILITIES	189,701	158,088
STOCKHOLDERS' DEFICIT:
Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)
Common stock ($.001 par value; 70,000,000 shares authorized; 37,493,120 and 36,443,119 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively)	37,493	36,443
Additional paid-in capital	124,573	114,570
Accumulated deficit	(343,975)	(307,306)
TOTAL STOCKHOLDERS' DEFICIT	(181,909)	(156,293)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 7,792	$ 1,795

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
BALANCE SHEETS
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	37,493,120	36,443,119
Common stock, shares outstanding	37,493,120	36,443,119

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
STATEMENTS OF OPERATIONS
Revenues
Operating Expenses:
General and administrative	7,621	1,398	13,477	5,771
Legal fees		5,000		30,060
Accounting fees	2,700	2,000	11,150	11,180
Transfer agent fees	1,129	300	2,039	1,450
Consulting fees		1,667		3,334
Total Operating Expenses	11,450	10,365	26,666	51,795
Loss from Operations	(11,450)	(10,365)	(26,666)	(51,795)
Other Expense:
Interest expense - related parties	(3,634)	(2,866)	(10,003)	(6,811)
Total Other Expense	(3,634)	(2,866)	(10,003)	(6,811)
Net Loss	$ (15,084)	$ (13,231)	$ (36,669)	$ (58,606)
Net Loss per common share, basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding:
Basic and diluted	36,979,533	36,443,119	36,623,229	36,443,119

Statements of Cash Flow

Statements of Cash Flow - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (36,669)	$ (58,606)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related parties loans	10,003	6,811
Changes in operating assets and liabilities:
Increase in prepaid expenses	(7,792)	(1,567)
Decrease in accounts payable	(3,180)	(3,546)
NET CASH USED IN OPERATING ACTIVITIES	(37,638)	(56,908)
CASH FLOWS FROM FINANCING ACTIVITIES:
Bank overdrafts	36
Proceeds from sale of common stock	1,050
Proceeds from loans from officer	34,757	57,871
NET CASH PROVIDED BY FINANCING ACTIVITIES	35,843	57,871
NET (DECREASE) INCREASE IN CASH	(1,795)	963
Cash, beginning of period	1,795	2,122
Cash, end of period		3,085
SUPPLEMENTAL DISCLOSURES:
Interest paid
Income taxes paid

Organization

Organization	9 Months Ended
	Sep. 30, 2016
Organization [Abstract]
Organization	NOTE 1 - Organization China Herb Group Holdings Corporation (the “Company”) was incorporated under the name “Island Radio, Inc” under the laws of the State of Nevada on June 28, 2010 . On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the “Sellers”), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the “Purchasers”), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the “Change in Control”). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company . The Company’s original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People’s Republic of China, the Company’s management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company’s plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company’s has extremely limited liquidity. Through September 30, 2016, the Company has no revenues or operation .

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - Summary of Significant Accounting Policies Unaudited Interim Financial Information The accompanying balance sheets as of September 30, 2016, statements of operations for the three and nine months ended September 30, 2016 and 2015, and the statements of cash flows for the nine months ended September 30, 2016 and 2015, are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America (“U.S. GAAP”). In the opinion of the Company’s management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company’s statement of financial position at September 30, 2016 and its results of operations and its cash flows for the period ended September 30, 2016. The results for the period ended September 30, 2016 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2016 . Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position as of September 30, 2016 and operating results for the three and nine months ended September 30, 2016 and 2015 . Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates . Fair Value of Financial Instruments ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value : Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities . Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data . Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities . As of September 30, 2016 and December 31, 2015, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations . Description Level 1 Level 2 Level 3 Total Realized Loss September 30, 2016 - - - - December 31, 2015 - - - - Total - - - - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments . Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of September 30, 2016 and December 31, 2015, the Company had no cash equivalents . Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized . The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of September 30, 2016 and December 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements . Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three and nine months ended September 30, 2016 and 2015, the Company had no dilutive financial instruments issued or outstanding . Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures .

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2016
Going Concern [Abstract]
Going Concern	NOTE 3 - Going Concern The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions . As of September 30, 2016, the Company did not have any cash and has been funding its working capital needs from loans from related parties. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company . The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United State of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of September 30, 2016, the Company had an accumulated deficit and stockholders’ deficit of $(343,975) and $(181,909), respectively. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern .

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 - Related Party Transactions Related Party Loans In year 2013, Chin Yung Kong, the director and shareholder of the Company, advanced $20,000 to the Company for working capital purposes. These working capital advances of $20,000 are payable on demand and, at September 30, 2016 and December 31, 2015, reflected as related party loans on the accompanying balance sheets . Starting from year 2014, Qiuping Lu, President, CEO, director and shareholder of the Company, advanced funds to the Company for working capital purposes. These working capital advances are payable on demand. As of September 30, 2016 and December 31, 2015, these working capital advances amounted to $168,505 and $133,748, respectively, are reflected as related party loans on the accompanying balance sheets . During the three months ended September 30, 2016 and 2015, in connection with these related party loans, the Company imputed interest of $3,634 and $2,866, respectively, and recorded interest expense and an increase in additional paid-in capital . During the nine months ended September 30, 2016 and 2015, in connection with these related party loans, the Company imputed interest of $10,003 and $6,811, respectively, and recorded interest expense and an increase in additional paid-in capital .

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2016
Stockholders Equity (Deficit) [Abstract]
Stockholders' Equity (Deficit)	NOTE 5 – Stockholders’ Equity (Deficit) Preferred Stock The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share . As of September 30, 2016 and December 31, 2015, the Company had no shares of its preferred stock issued and outstanding . Common Stock The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share . As of September 30, 2016 and December 31, 2015, the Company had 37,493,120 and 36,443,119 shares of its common stock issued and outstanding, respectively . Common Stock Sold for Cash On August 15, 2016, the Company sold 1,050,001 shares of common stock at a purchase price of $0.001 per share to 28 investors pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $1,050.

Commitments

Commitments	9 Months Ended
	Sep. 30, 2016
Commitments [Abstract]
Commitments	NOTE 6 - Commitments On April 4, 2014 the Company entered into a memorandum of understanding (the “MOU”) with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence were to provide certain services to the Company and the Company was to have issued 10% of the issued and outstanding shares of the Company’s common stock to each of Dr. Pandelisev and Ms. Lawrence upon the completion of a reverse merger with a previously identified operating company, which reverse merger did not and will not take place. Pursuant to ASC 505-50, the Company did not recognize any expense during the period since the issuance of these shares is contingent upon the completion of a specific merger. Accordingly, no performance commitment has been reached nor has performance been completed .

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	NOTE 7 – Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined there are no additional events required to be disclosed .

Summary of Significant Accoun13

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Summary of Significant Accounting Policies [Abstract]
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying balance sheets as of September 30, 2016, statements of operations for the three and nine months ended September 30, 2016 and 2015, and the statements of cash flows for the nine months ended September 30, 2016 and 2015, are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America (“U.S. GAAP”). In the opinion of the Company’s management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company’s statement of financial position at September 30, 2016 and its results of operations and its cash flows for the period ended September 30, 2016. The results for the period ended September 30, 2016 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2016 .
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position as of September 30, 2016 and operating results for the three and nine months ended September 30, 2016 and 2015 .
Use of Estimates	Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates .
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value : Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities . Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data . Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities . As of September 30, 2016 and December 31, 2015, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations . Description Level 1 Level 2 Level 3 Total Realized Loss September 30, 2016 - - - - December 31, 2015 - - - - Total - - - - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments .
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of September 30, 2016 and December 31, 2015, the Company had no cash equivalents .
Income Taxes	Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized . The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of September 30, 2016 and December 31, 2015, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements .
Loss per Share Calculation	Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three and nine months ended September 30, 2016 and 2015, the Company had no dilutive financial instruments issued or outstanding .
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures .

Summary of Significant Accoun14

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2016
Summary of Significant Accounting Policies [Abstract]
Summary of financial instruments of fair value current	Description Level 1 Level 2 Level 3 Total Realized Loss September 30, 2016 - - - - December 31, 2015 - - - - Total - - - -

Organization (Details)

Organization (Details)	Jun. 27, 2012USD ($)shares
Organization (Textual)
Issuance of company's common stock, shares | shares	4,000,000
Percentage of company's common stock issued and outstanding	93.00%
Total purchase price | $	$ 159,970

Summary of Significant Accoun16

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss

Going Concern (Details)

Going Concern (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Going Concern (Textual)
Accumulated deficit	$ (343,975)	$ (307,306)
Stockholders' deficit	$ (181,909)	$ (156,293)

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2013
Related Parties Transactions (Textual)
Due to related parties	$ 188,505		$ 188,505		$ 153,748
Imputed interest	2,866	$ 3,634	10,003	$ 6,811
Working capital advances	20,000		20,000		20,000
Qiuping Lu [Member]
Related Parties Transactions (Textual)
Working capital advances	$ 168,505		$ 168,505		$ 133,748
Chin Yung Kong [Member]
Related Parties Transactions (Textual)
Due to related parties						$ 20,000

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details)	Aug. 15, 2016USD ($)Individuals$ / sharesshares	Sep. 30, 2016USD ($)$ / sharesshares	Dec. 31, 2015$ / sharesshares
Stockholders' Equity (Deficit) (Textual)
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value | $ / shares		$ 0.001	$ 0.001
Preferred stock, shares issued		0	0
Preferred stock, shares outstanding		0	0
Common stock, shares authorized		70,000,000	70,000,000
Common stock, par value | $ / shares		$ 0.001	$ 0.001
Common stock, shares issued		37,493,120	36,443,119
Common stock, shares outstanding		37,493,120	36,443,119
Sale of common stock shares	1,050,001
Purchase, price per share | $ / shares	$ 0.001
Number of investors | Individuals	28
Proceeds from sale of common stock | $	$ 1,050	$ 1,050

Commitments (Details)

Commitments (Details)	9 Months Ended
	Sep. 30, 2016
Commitments (Textual)
Commitment description	The Company entered into a memorandum of understanding (the "MOU") with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence were to provide certain services to the Company and the Company was to have issued 10% of the issued and outstanding shares of the Company's common stock to each of Dr. Pandelisev and Ms. Lawrence.